These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16518292)

  • 1. [Acute colitis closely following the beginning of celecoxib treatment].
    Houmani Z; Imbert A; Duchmann JC; Messerschmitt C; Barbare JC; Latrive JP; Biour M
    Gastroenterol Clin Biol; 2005 Dec; 29(12):1294-5. PubMed ID: 16518292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ulcerating haemorrhagic colitis induced by celecoxib].
    Rey P; Andriamanantena D; Carrère C; Casassus-Builhè D; Hamant N; Perret JL
    Presse Med; 2005 Mar; 34(6):443-5. PubMed ID: 15902876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute pancreatitis after treatment by celecoxib].
    Mennecier D; Ceppa F; Sinayoko L; Corberand D; Harnois F; Thiolet C; Farret O
    Gastroenterol Clin Biol; 2007; 31(8-9 Pt 1):668-9. PubMed ID: 17925765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease.
    Miao XP; Li JS; Ouyang Q; Hu RW; Zhang Y; Li HY
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD007744. PubMed ID: 25340915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Meloxicam-induced colitis revealed by acute abdominal pain].
    Seddik H; Rabhi M
    Ann Pharm Fr; 2013 Mar; 71(2):119-22. PubMed ID: 23537413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute cholestatic hepatitis associated with celecoxib.
    Grieco A; Miele L; Giorgi A; Civello IM; Gasbarrini G
    Ann Pharmacother; 2002 Dec; 36(12):1887-9. PubMed ID: 12452750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged cholestasis associated with short-term use of celecoxib.
    Chamouard P; Walter P; Baumann R; Poupon R
    Gastroenterol Clin Biol; 2005 Dec; 29(12):1286-8. PubMed ID: 16518289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of celecoxib in the treatment of acute pain due to ankle sprain in a Latin American and Middle Eastern population.
    Cardenas-Estrada E; Oliveira LG; Abad HL; Elayan F; Khalifa N; El-Usseini T
    J Int Med Res; 2009; 37(6):1937-51. PubMed ID: 20146894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults.
    Huang WF; Hsiao FY; Wen YW; Tsai YW
    Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
    Goldstein JL; Cryer B; Amer F; Hunt B
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1167-74. PubMed ID: 17916545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hepatic safety and tolerability of the cyclooxygenase-2 selective NSAID celecoxib: pooled analysis of 41 randomized controlled trials.
    Soni P; Shell B; Cawkwell G; Li C; Ma H
    Curr Med Res Opin; 2009 Aug; 25(8):1841-51. PubMed ID: 19530981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. By the way, doctor. Celebrex and bleeding.
    Komaroff A
    Harv Health Lett; 2008 May; 33(7):8. PubMed ID: 18700242
    [No Abstract]   [Full Text] [Related]  

  • 13. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial.
    Chan FK; Lanas A; Scheiman J; Berger MF; Nguyen H; Goldstein JL
    Lancet; 2010 Jul; 376(9736):173-9. PubMed ID: 20638563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of celecoxib in patients with cutaneous reactions due to ASA-NSAIDs intolerance.
    Andri L; Falagiani P
    Allergol Immunopathol (Madr); 2007; 35(4):126-9. PubMed ID: 17663920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials.
    White WB; West CR; Borer JS; Gorelick PB; Lavange L; Pan SX; Weiner E; Verburg KM
    Am J Cardiol; 2007 Jan; 99(1):91-8. PubMed ID: 17196469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypersensitivity to celecoxib].
    Fradet G; Robin-Le Nechet A; Huguenin H; Chiffoleau A
    Ann Med Interne (Paris); 2003 May; 154(3):181-2. PubMed ID: 12910047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor.
    Goldstein JL; Lowry SC; Lanza FL; Schwartz HI; Dodge WE
    Aliment Pharmacol Ther; 2006 May; 23(10):1489-98. PubMed ID: 16669964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are COX-2 inhibitors safe for anyone.
    Bloomfeld RS
    Inflamm Bowel Dis; 2006 Sep; 12(9):922-3. PubMed ID: 16954813
    [No Abstract]   [Full Text] [Related]  

  • 19. Gastrointestinal safety of amtolmetin guacyl in comparison with celecoxib in patients with rheumatoid arthritis.
    Jajić Z; Malaise M; Nekam K; Koó E; Dankó K; Kovacs M; Scarpignato C
    Clin Exp Rheumatol; 2005; 23(6):809-18. PubMed ID: 16396699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib-induced acute pancreatitis and hepatitis: a case report.
    Carrillo-Jimenez R; Nurnberger M
    Arch Intern Med; 2000 Feb; 160(4):553-4. PubMed ID: 10695699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.